Capecitabine maintenance after first-line induction chemotherapy with docetaxel cisplatin, and fluorouracil in patients with advanced gastric cancer

被引：1
|
作者：
Oyan, Basak [1 ]
Eren, Orhan Onder [1 ]
Sonmez, Ozlem [1 ]
机构：
[1] Yeditepe Univ Hosp, Med Oncol Sect, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15003
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Kang, Yoon-Koo
    Ryu, Min-Hee
    Yoo, Changhoon
    Chang, Heung-Moon
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Tae Won
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1435 - 1443
  • [2] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Yoon-Koo Kang
    Min-Hee Ryu
    Changhoon Yoo
    Heung-Moon Chang
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Tae Won Kim
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1435 - 1443
  • [3] CISPLATIN AND DOCETAXEL AS FIRST LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Marrupe, D.
    Garcia, S.
    Lopez, E.
    Mendez, M.
    Quiben, R.
    ANNALS OF ONCOLOGY, 2010, 21 : 112 - 113
  • [4] Phase II study of docetaxel, cisplatin, and 5-fluorouracil (TPF) as first-line chemotherapy in advanced gastric cancer
    Chowdhury, Q.
    Hossain, S.
    Reza, S.
    Hai, M. A.
    Faruqui, M.
    Morshed, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer
    Kim, TW
    Kang, YK
    Ahn, JH
    Chang, HM
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1893 - 1898
  • [6] Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer
    Petrioli, Roberto
    Francini, Edoardo
    Cherri, Sara
    Marrelli, Daniele
    Rovello, Franco
    Fiaschi, Anna Ida
    Miano, Salvatora Tindara
    Savelli, Vinno
    Calomino, Natale
    Farsi, Marco
    Vernillo, Remo
    Francini, Guido
    ANTI-CANCER DRUGS, 2020, 31 (03) : 292 - 297
  • [7] Epirubicin (E), cisplatin (C) and capecitabine (X) in first-line chemotherapy for patients with advanced gastric cancer.
    Cho, EK
    Lee, WK
    Im, SA
    Lee, SN
    Park, SH
    Bang, SM
    Shin, DB
    Lee, JH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 331S - 331S
  • [8] CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN AND CAPECITABINE (DCX) FOR ADVANCED GASTRIC CANCER
    Maeda, O.
    Ando, T.
    Ishiguro, K.
    Watanabe, O.
    Miyahara, R.
    Funasaka, K.
    Ando, Y.
    Goto, H.
    ANNALS OF ONCOLOGY, 2013, 24 : 34 - 34
  • [9] DOCETAXEL, CISPLATIN, 5-FLUOROURACIL AND LEUCOVORIN AS FIRST-LINE THERAPY IN ADVANCED GASTRIC CANCER (AGC)
    Trusilova, E.
    Besova, N.
    Gorbunova, V. A.
    ANNALS OF ONCOLOGY, 2012, 23 : 250 - 251
  • [10] A phase I/II trial of docetaxel, capecitabine, and cisplatin as a first line chemotherapy for advanced gastric cancer.
    Kang, YK
    Kim, TW
    Chang, HM
    Ryu, MH
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 329S - 329S
12345